Comparison of Short-Term Outcomes and Safety Profiles between Androgen Deprivation Therapy+Abiraterone/Prednisone and Androgen Deprivation Therapy+Docetaxel in Patients with De Novo Metastatic Hormone-Sensitive Prostate Cancer.
Park DJ, Kwon TG, Park JY, Joung JY, Ha HK, Jeon SS, Hong SH, Park S, Lee SH, Cho JS, Park SW, Kwon SY, Jo JK, Park HS, Lee SC, Kwon DD, Kim SI, Park SH, Kim S, Jeong CW, Kwak C, Choi SH; Korean Urologic Oncology Society Prostate Cancer Group.
Park DJ, et al. Among authors: park jy, park s, park hs, park sh, park sw.
World J Mens Health. 2024 Jul;42(3):620-629. doi: 10.5534/wjmh.230104. Epub 2024 Jan 2.
World J Mens Health. 2024.
PMID: 38164028
Free PMC article.